pharmaceutical investing Pfizer Showcases Oncology Innovation and Next-Generation Pipeline at ASCO 2026
pharmaceutical investing U.S. FDA Grants Priority Review to sBLA for PADCEV + Keytruda® as Perioperative Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility
pharmaceutical investing Pfizer Invites Shareholders to View and Listen to Webcast of April 23 Virtual 2026 Annual Meeting of Shareholders
pharmaceutical investing Pfizer Invites Shareholders to View and Listen to Webcast of April 23 Virtual 2026 Annual Meeting of Shareholders
pharmaceutical investing Pfizer Invites Public to View and Listen to Webcast of May 5 Conference Call with Analysts
pharmaceutical investing Pantera Minerals Limited High-Grade Antimony to 3.9% Sb and Extensive Soil Anomalies Confirm Priority Drill Targets
pharmaceutical investing Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial
pharmaceutical investing TALZENNA Plus XTANDI Significantly Improves Radiographic Progression-Free Survival in Metastatic Prostate Cancer
pharmaceutical investing Pfizer Announces Positive Topline Phase 2 Results for Next-Generation CDK4 Inhibitor, Atirmociclib, in Second-Line Metastatic Breast Cancer
pharmaceutical investing ViiV Healthcare reports positive 12-month data showing investigational bNAb lotivibart maintains high levels of viral suppression in long-acting HIV treatment regimen
pharmaceutical investing U.S. FDA Grants Full Approval to Pfizer's BRAFTOVI Combination Regimen in First-Line Metastatic Colorectal Cancer
Allied Critical Metals Announces Transformative U.S.$40 Million Financing Package to Fast-Track Tungsten Concentrates Production
Syntholene Energy Announces DTC Eligibility and Provides Update Regarding Investor Relations Activity
